| NCT ID | NCT03942081 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linnea Polgreen |
| Condition | Foot Ulcer |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-09-05 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2017-09-05 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
All study procedures will occur during one appointment. The research team will measure the size of the foot ulcer (if one is present) and multiple photos will be taken with a smart phone camera and thermal camera. Demographic information will be obtained from the medical record.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with Type 1 or Type 2 Diabetes * Has a current foot lesion * Receiving care through University of Iowa Hospitals and Clinics (UIHC) Iowa River Landing Diabetes Clinic, UIHC Internal Medicine Clinic, or UIHC Orthopedic Clinic. Exclusion Criteria: * Cognitive impairment that prevents consent * Lack of fluency in speaking or understanding English * Known aversion to research studies
Contact & Investigator
Linnea Polgreen, PhD
PRINCIPAL INVESTIGATOR
University of Iowa
Frequently Asked Questions
Who can join the NCT03942081 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 100 Years, studying Foot Ulcer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03942081 currently recruiting?
Yes, NCT03942081 is actively recruiting participants. Contact the research team at linnea-polgreen@uiowa.edu for enrollment information.
Where is the NCT03942081 trial being conducted?
This trial is being conducted at Iowa City, United States.
Who is sponsoring the NCT03942081 clinical trial?
NCT03942081 is sponsored by Linnea Polgreen. The principal investigator is Linnea Polgreen, PhD at University of Iowa. The trial plans to enroll 500 participants.